Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation

Clinical trial NCT01067287 · COMPLETED

Trial details

NCT number: NCT01067287
Sponsor: Beth Israel Deaconess Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2010-03-01
Primary completion: 2025-09-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.